Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma

✍ Scribed by Hsu, C-H; Yang, T-S; Hsu, C; Toh, H C; Epstein, R J; Hsiao, L-T; Chen, P-J; Lin, Z-Z; Chao, T-Y; Cheng, A-L

• Book ID: 110000379
• Publisher: Nature Publishing Group
• Year: 2010
• Tongue: English
• Weight: 284 KB
• Volume: 102
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/sj.bjc.6605580